EDGAR Filing Documents for 0001437749-22-008751

Form 8-K - Current report:

SEC Accession No. 0001437749-22-008751

Filing Date

2022-04-12

Accepted

2022-04-12 16:11:28

Documents

Period of Report

2022-04-07

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	navb20220411_8k.htm iXBRL	8-K	72240
2	EXHIBIT 3.1	ex_357564.htm	EX-3.1	37430
3	EXHIBIT 3.2	ex_357565.htm	EX-3.2	90689
4	EXHIBIT 3.3	ex_357566.htm	EX-3.3	43123
5	EXHIBIT 4.1	ex_357567.htm	EX-4.1	409930
6	EXHIBIT 10.1	ex_357568.htm	EX-10.1	365720
7	EXHIBIT 10.2	ex_357569.htm	EX-10.2	14742
8	EXHIBIT 10.3	ex_357570.htm	EX-10.3	36076
9	EXHIBIT 10.4	ex_357571.htm	EX-10.4	155442
10	EXHIBIT 99.1	ex_357572.htm	EX-99.1	11286
11	EXHIBIT 99.2	ex_357573.htm	EX-99.2	17311
	Complete submission text file	0001437749-22-008751.txt		1641832

Data Files

Seq	Description	Document	Type	Size
12	XBRL TAXONOMY EXTENSION SCHEMA	navb-20220407.xsd	EX-101.SCH	3601
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	navb-20220407_def.xml	EX-101.DEF	12303
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE	navb-20220407_lab.xml	EX-101.LAB	16508
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	navb-20220407_pre.xml	EX-101.PRE	12569
17	EXTRACTED XBRL INSTANCE DOCUMENT	navb20220411_8k_htm.xml	XML	2782

Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017

Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500

NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)